Tandem Diabetes Care, Inc.

BOVESPA:T2ND34 Stock Report

Market Cap: R$15.1b

Tandem Diabetes Care Management

Management criteria checks 3/4

Tandem Diabetes Care's CEO is John Sheridan, appointed in Apr 2013, has a tenure of 11.42 years. total yearly compensation is $4.65M, comprised of 15.3% salary and 84.7% bonuses, including company stock and options. directly owns 0.076% of the company’s shares, worth R$11.48M. The average tenure of the management team and the board of directors is 3 years and 4.2 years respectively.

Key information

John Sheridan

Chief executive officer

US$4.7m

Total compensation

CEO salary percentage15.3%
CEO tenure11.4yrs
CEO ownership0.08%
Management average tenure3yrs
Board average tenure4.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has John Sheridan's remuneration changed compared to Tandem Diabetes Care's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$136m

Mar 31 2024n/an/a

-US$141m

Dec 31 2023US$5mUS$711k

-US$223m

Sep 30 2023n/an/a

-US$208m

Jun 30 2023n/an/a

-US$224m

Mar 31 2023n/an/a

-US$204m

Dec 31 2022US$6mUS$711k

-US$95m

Sep 30 2022n/an/a

-US$68m

Jun 30 2022n/an/a

-US$13m

Mar 31 2022n/an/a

US$6m

Dec 31 2021US$6mUS$690k

US$16m

Sep 30 2021n/an/a

US$22m

Jun 30 2021n/an/a

US$7m

Mar 31 2021n/an/a

-US$25m

Dec 31 2020US$4mUS$600k

-US$34m

Sep 30 2020n/an/a

-US$49m

Jun 30 2020n/an/a

-US$42m

Mar 31 2020n/an/a

-US$17m

Dec 31 2019US$11mUS$500k

-US$25m

Sep 30 2019n/an/a

-US$24m

Jun 30 2019n/an/a

-US$55m

Mar 31 2019n/an/a

-US$113m

Dec 31 2018US$2mUS$386k

-US$123m

Sep 30 2018n/an/a

-US$138m

Jun 30 2018n/an/a

-US$119m

Mar 31 2018n/an/a

-US$82m

Dec 31 2017US$596kUS$375k

-US$73m

Compensation vs Market: John's total compensation ($USD4.65M) is above average for companies of similar size in the BR market ($USD1.51M).

Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.


CEO

John Sheridan (69 yo)

11.4yrs

Tenure

US$4,651,603

Compensation

Mr. John F. Sheridan has been President and Chief Executive Officer at Tandem Diabetes Care, Inc., since March 01, 2019 and served as its Chief Operating Officer and Executive Vice President since April 20...


Leadership Team

NamePositionTenureCompensationOwnership
John Sheridan
President11.4yrsUS$4.65m0.076%
$ 11.5m
Leigh Vosseller
Executive VP6.7yrsUS$1.25m0.049%
$ 7.4m
Susan Morrison
Executive VP & Chief Administrative Officer11yrsUS$1.25m0.036%
$ 5.4m
David Berger
Transitional Advisorless than a yearUS$1.25m0.011%
$ 1.6m
Elizabeth Gasser
Executive Vice President and Chief Strategy & Product Officer3.3yrsUS$1.25m0.020%
$ 3.0m
Mark Novara
Executive VP & Chief Commercial Officerless than a yearUS$2.72mno data
Jean-Claude Kyrillos
Executive VP & COOless than a yearno datano data
Rick Carpenter
Chief Technical Officer2.8yrsno data0.020%
$ 3.0m
Shannon Hansen
Executive VP2.7yrsno data0.018%
$ 2.7m
Tom Fox
Chief Human Resources Officer7.1yrsno datano data
Jordan Pinsker
Chief Medical Officerless than a yearno datano data
James Leal
Chief Manufacturing Officer7.1yrsno data0.026%
$ 3.9m

3.0yrs

Average Tenure

56yo

Average Age

Experienced Management: T2ND34's management team is considered experienced (3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
John Sheridan
President5.3yrsUS$4.65m0.076%
$ 11.5m
Rebecca Robertson
Independent Chairwoman of the Board5.7yrsUS$222.78k0.014%
$ 2.2m
Kim Blickenstaff
Chair Emeritusless than a yearUS$198.78k0.34%
$ 51.5m
Christopher Twomey
Independent Director11.2yrsUS$200.95k0.037%
$ 5.5m
Dick Allen
Independent Director17.2yrsUS$214.67k0.059%
$ 8.9m
Peyton Howell
Independent Director4.1yrsUS$190.28k0.025%
$ 3.9m
Rajwant Sodhi
Independent Director3.7yrsUS$189.25k0.017%
$ 2.6m
Kathleen McGroddy-Goetz
Independent Director4.3yrsUS$189.25k0.021%
$ 3.1m
Myoungil Cha
Independent Director2.3yrsUS$176.55k0.012%
$ 1.7m
Joao Paulo Malagueira
Independent Director2.3yrsUS$177.55k0.012%
$ 1.7m

4.2yrs

Average Tenure

61.5yo

Average Age

Experienced Board: T2ND34's board of directors are considered experienced (4.2 years average tenure).